Shimada, K
Shimada, S
Sugimoto, K
Nakatochi, M http://orcid.org/0000-0002-1838-4837
Suguro, M
Hirakawa, A
Hocking, T D
Takeuchi, I
Tokunaga, T
Takagi, Y
Sakamoto, A
Aoki, T
Naoe, T
Nakamura, S
Hayakawa, F
Seto, M
Tomita, A
Kiyoi, H
Article History
Received: 22 October 2015
Revised: 11 February 2016
Accepted: 4 March 2016
First Online: 22 March 2016
Competing interests
: K Sugimoto is an employee of Otsuka Pharmaceutical Co., Ltd and M Seto is an employee of Immuno-Biological Laboratories Co., Ltd. TN received research funding from Astellas Pharma Inc., Celgene KK, Fujifilm Corporation, Kyowa-Hakko Kirin Co., Ltd, Nippon Boehringer Ingelheim Co., Ltd, Otsuka Pharmaceutical Co., Ltd, Pfizer Inc. and Toyoma Chemical Co., Ltd, has issued patents and royalties with Chugai Pharmaceutical Co., Ltd, and Kyowa-Hakko Kirin Co., Ltd and has pending patents and royalties with Fujifilm Corporation. HK has served as a consultant for Astellas Pharma Inc. and Kyowa-Hakko Kirin Co., Ltd and has received research funding from Fujifilm Corporation, Nippon Boehringer Ingelheim Co., Ltd, Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd, Kyowa-Hakko Kirin Co., Ltd, Zenyaku Kogyo Company Ltd, FUJIFILM RI Pharma Co., Ltd, Nippon Shinyaku Co., Ltd, the Japan Blood Products Organization, Astellas Pharma Inc., Eisai Co., Ltd, Yakult Honsha Co., Ltd, Pfizer Inc., Takeda Pharmaceutical Co., Ltd, MSD K.K., Alexion Pharmaceuticals, Teijin Ltd, Mochida Pharmaceutical Co., Ltd, Sumitomo Dainippon Pharma Co., Ltd, Taisho Toyama Pharmaceutical Co., Ltd and Novartis Pharma K.K. and has patents and royalties with Fujifilm Corporation.